Biosyent Inc opened trading today at $8.65 and closed at $8.65. prices ranged from a low of $8.62 to a high of $8.65.

Shares advanced 0.58 percent from the previous day's close of $8.60.

Today across North America, the TSX Composite closed -0.40% at 22110.11, the S&P 500 closed 0.74% at 5199.06, the Dow Jones Industrial Average closed -0.01% at 38459.08 and the Nasdaq Composite closed 1.68% at 16442.20.

Biosyent Inc has listed on the Toronto Venture Exchange (TSX-V) under the ticker RX.

Trading volume was 2,200 on 8 total trades, with an average volume of 11,317 over the last 5 days.

The TSX-V market on the whole today saw 788 price advancers against 4,485 declines and 84 unchanged.

During the prior 52 weeks, RX.VN has traded as high as $9.26 (December 29,2023) and low as $7.03 (July 06,2023). Moreover, in the last 12 months, Biosyent Inc's shares have advanced 12.34%, while they have eased -6.18% since the start of 2024.

It announced a 0.04 dividend on February 07/24, with an February 28/24 ex-date and March 15/24 pay day.

Following today's trading, Biosyent Inc has a market capitalization of $99.91 million on a float of 11,618 shares outstanding. Its annual EPS is $0.53.

Biosyent Inc is a TSX Drug Specialty & Generic company headquartered in Mississauga, CAN.

Currently, Biosyent Inc's consensus rating is "Moderate Buy" based on 1 analysts according to Zacks. Currently, there are 1 buy ratings for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..